Septodont Holding Drug Patent Portfolio

Septodont Holding owns 1 orange book drug protected by 5 US patents Given below is the list of Septodont Holding's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7575757 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 21 Apr, 2025
Active
US7569230 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 17 Oct, 2023 Expired
US7229630 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 20 Jun, 2023 Expired
US6764678 Local anesthetic methods and kits 11 May, 2021 Expired
US6872390 Local anesthetic methods and kits 11 May, 2021 Expired


Given below is the list of recent legal activities going on the following drug patents of Septodont Holding.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 08 Feb, 2021 US7575757
Payment of Maintenance Fee, 12th Year, Large Entity 25 Jan, 2021 US7569230
Payment of Maintenance Fee, 12th Year, Large Entity 03 Dec, 2018 US7229630
Request for Trial Granted in Part 06 Nov, 2016 US7575757
Petition Requesting Trial 06 Nov, 2016 US7575757
Termination or Final Written Decision 06 Nov, 2016 US7575757
Request for Trial Granted 08 Jul, 2016 US7575757
Petition Requesting Trial 08 Jul, 2016 US7575757
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 30 Dec, 2010 US7229630
Patent Issue Date Used in PTA Calculation 18 Aug, 2009 US7575757
Recordation of Patent Grant Mailed 18 Aug, 2009 US7575757
Recordation of Patent Grant Mailed 04 Aug, 2009 US7569230
Patent Issue Date Used in PTA Calculation 04 Aug, 2009 US7569230
Issue Notification Mailed 29 Jul, 2009 US7575757
Issue Notification Mailed 15 Jul, 2009 US7569230


Septodont Holding's Family Patents

Septodont Holding drugs have patent protection in a total of 12 countries. It's US patent count contributes only to 43.5% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Septodont Holding Drug List

Given below is the complete list of Septodont Holding's drugs and the patents protecting them.


1. Oraverse

Oraverse is protected by 5 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7575757 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 21 Apr, 2025
(4 months from now)
Active
US7569230 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 17 Oct, 2023
(1 year, 2 months ago)
Expired
US7229630 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof 20 Jun, 2023
(1 year, 5 months ago)
Expired
US6764678 Local anesthetic methods and kits 11 May, 2021
(3 years ago)
Expired
US6872390 Local anesthetic methods and kits 11 May, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oraverse's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List